On September 17, 2024, Neuralink, the brain-chip startup founded by Elon Musk, announced that its experimental implant, known as Blindsight, has received breakthrough device designation from the U.S. Food and Drug Administration (FDA). This significant milestone is aimed at restoring vision for individuals who have lost their sight, including those who have lost both eyes and their optic nerve